SEROCONVERSION

作品数:35被引量:227H指数:9
导出分析报告
相关领域:医药卫生更多>>
相关作者:熊永红孔香兰杨德云更多>>
相关机构:新疆医科大学第五附属医院更多>>
相关期刊:《Cellular & Molecular Immunology》《Science China(Life Sciences)》《World Journal of Gastroenterology》《Journal of Health Science》更多>>
相关基金:国家自然科学基金广东省自然科学基金国家重点基础研究发展计划国家教育部博士点基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 主题=HEPATITISx
条 记 录,以下是1-7
视图:
排序:
Seroconversion of HBsAG coincides with hepatitis A superinfection: A case report被引量:1
《World Journal of Clinical Cases》2020年第9期1651-1655,共5页Claudia Beisel Marylyn M Addo Julian Schulze zur Wiesch 
BACKGROUND Hepatitis B virus(HBV)is a hepatotropic virus that can cause acute and chronic liver damage.According to the world health organization 257 million people are infected with chronic HBV infection worldwide.Su...
关键词:Chronic HEPATITIS B INFECTION Liver cirrhosis Acute HEPATITIS A INFECTION HBSAG clearance Functional CURE Case report 
Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients被引量:22
《World Journal of Gastroenterology》2019年第6期719-728,共10页Hao Luo Xia-Xia Zhang Li-Hua Cao Ning Tan Qian Kang Hong-Li Xi Min Yu Xiao-Yuan Xu 
the 13th Five-Year Plan,No.2018ZX09206005-002
BACKGROUND Characteristics of alterations of serum hepatitis B virus(HBV) RNA in different chronic hepatitis B(CHB) patients still cannot be fully explained. Whether HBV RNA can predict HBeAg seroconversion is still c...
关键词:Chronic HEPATITIS B HEPATITIS B virus RNA Virological response HBeAg SEROCONVERSION ENTECAVIR 
Seroconversion of Hepatitis B and Hepatitis C among Hemodialysis Patients,Baghdad,2015
《Journal of Health Science》2019年第1期23-28,共6页Riyadh Mraweh Ibrahim Bushra Jabbar Hashem 
Hepatitis C&B still the major problem in hemodialysis patients and the challenge continues in dialysis centers to prevent spread among patients and workers,the worldwide reported incidence of anti-HC antibody in dialy...
关键词:SEROCONVERSION SEROPREVALENCE HEMODIALYSIS HEPATITIS 
Clinical features of HBs Ag seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study被引量:4
《World Journal of Gastroenterology》2016年第44期9836-9843,共8页Young Min Park Seong Gyu Lee 
AIM To investigate the characteristic features of hepatitis B surface antigen(HBs Ag) seroclearance among Korean hepatitis B virus(HBV) carriers.METHODS Carriers with HBs Ag seroclearance were selected by analyzing lo...
关键词:Hepatocellular carcinoma HEPATITIS B virus HEPATITIS B Surface ANTIGEN HBS AG SEROCONVERSION HEPATITIS B e ANTIGEN HBE AG Liver cirrhosis 
Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients被引量:14
《World Journal of Gastroenterology》2015年第18期5668-5676,共9页Chang-Tai Wang Ya-Fei Zhang Bing-Hu Sun Yu Dai Hui-Lan Zhu Yuan-Hong Xu Meng-Ji Lu Dong-Liang Yang Xu Li Zhen-Hua Zhang 
Supported by Specialized Research Fund for the Doctoral Program of Higher Education of China,No.20093420120005;National Science Foundation of China,No.30771907
AIM:To develop models to predict hepatitis B e antigen(HBe Ag)seroconversion in response to interferon(IFN)-αtreatment in chronic hepatitis B patients.METHODS:We enrolled 147 treatment-nave HBe Agpositive chronic h...
关键词:CHRONIC HEPATITIS B INTERFERON HEPATITIS B e ANTIGEN Treatment Model 
Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion被引量:4
《World Journal of Gastroenterology》2015年第2期541-548,共8页Nozomi Kamijo Akihiro Matsumoto Takeji Umemura Soichiro Shibata Yuki Ichikawa Takefumi Kimura Michiharu Komatsu Eiji Tanaka 
Supported by Research grant from the Ministry of Health,Labor,and Welfare of Japan
AIM: To investigate the role of pre-core and basal core promoter(BCP) mutations before and after hepatitis Be antigen(HBe Ag) seroconversion.METHODS: The proportion of pre-core(G1896A) and basal core promoter(A1762T a...
关键词:SEROCONVERSION HEPATITIS B core-related ANTIGEN Pr 
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients被引量:7
《World Journal of Gastroenterology》2010年第43期5447-5451,共5页Sylvia Brost Paul Schnitzler Wolfgang Stremmel Christoph Eisenbach 
AIM: To study the efficacy and safety of entecavir (ETV) as first-line therapy for hepatitis B virus (HBV) reactivation due to immunosuppression. METHODS: Four patients that were treated with different immunosuppressi...
关键词:HEPATITIS B virus ENTECAVIR IMMUNOSUPPRESSION HEPATITIS B surface antigen SEROCONVERSION 
检索报告 对象比较 聚类工具 使用帮助 返回顶部